|
Sánchez-Lorencio MI, Ramirez P, Saenz L, Martínez Sánchez MV, De La Orden V, Mediero-Valeros B, Veganzones-De-Castro S, Baroja-Mazo A, Revilla Nuin B, Gonzalez MR, Cascales-Campos PA, Noguera-Velasco JA, Minguela A, Díaz-Rubio E, Pons JA, Parrilla P. Comparison of Two Types of Liquid Biopsies in Patients With Hepatocellular Carcinoma Awaiting Orthotopic Liver Transplantation. Transplant Proc. 2015 Nov;47(9):2639-42. doi: 10.1016/j.transproceed.2015.10.003. PubMed PMID: 26680058.
AÑO: 2015; IF: 0.867
|
26680058
|
Martínez-Laorden E, García-Carmona JA, Baroja-Mazo A, Romecín P, Atucha NM, Milanés MV, Laorden ML. Corticotropin-releasing factor (CRF) receptor-1 is involved in cardiac noradrenergic activity observed during naloxone-precipitated morphine withdrawal. Br J Pharmacol. 2014 Feb;171(3):688-700. doi: 10.1111/bph.12511. PubMed PMID: 24490859; PubMed Central PMCID: PMC3969081.
AÑO: 2014; IF: 8.739
|
|
Baroja-Mazo A, Martín-Sánchez F, Gomez AI, Martínez CM, Amores-Iniesta J, Compan V, Barberà-Cremades M, Yagüe J, Ruiz-Ortiz E, Antón J, Buján S, Couillin I, Brough D, Arostegui JI, Pelegrín P. The NLRP3 inflammasome is released as a particulate danger signal that amplifies the inflammatory response. Nat Immunol. 2014 Aug;15(8):738-48. doi: 10.1038/ni.2919. PubMed PMID: 24952504.
AÑO: 2014; IF: 20.004
|
|
Baroja-Mazo A, Barberà-Cremades M, Pelegrín P. The participation of plasma membrane hemichannels to purinergic signaling. Biochim Biophys Acta. 2013 Jan;1828(1):79-93. doi: 10.1016/j.bbamem.2012.01.002. Review. PubMed PMID: 22266266.
AÑO: 2013; IF: 3.431
|
|
Baroja-Mazo A, Barberà-Cremades M, Pelegrín P. P2X7 receptor activation impairs exogenous MHC class I oligopeptides presentation in antigen presenting cells. PLoS One. 2013 Aug 5;8(8):e70577. doi: 10.1371/journal.pone.0070577. PubMed PMID: 23940597; PubMed Central PMCID: PMC3734297.
AÑO: 2013; IF: 3.534
|